The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C†
Open accessAbstract
UNLABELLED: 25-Hydroxyvitamin D (25[OH]D) can potentially interfere with inflammatory response and fibrogenesis. Its role in disease progression in chronic hepatitis C (CHC) and its relation with histological and sustained virological response (SVR) to therapy are unknown. One hundred ninety-seven patients with biopsy-proven genotype 1 (G1) CHC and 49 healthy subjects matched by age and sex were consecutively evaluated. One hundred sixty-seven patients underwent antiviral therapy with pegylated interferon plus ribavirin. The 25(OH)D serum levels were measured by high-pressure liquid chromatography. Tissue expression of cytochrome (CY) P27A1 and CYP2R1, liver 25-hydroxylating enzymes, were assessed by immunochemistry in 34 patients with CHC, and in eight controls. The 25(OH)D serum levels were significantly lower in CHC than in controls (25.07 +/- 9.92 microg/L versus 43.06 +/- 10.19; P < 0.001). Lower levels of 25(OH)D were independently linked to female sex (P = 0.007) and necroinflammation (P = 0.04) by linear regression analysis. CYP27A1, but not CYP2R1, was directly related to 25(OH)D levels (P = 0.01), and inversely to necroinflammation (P = 0.01). Low 25(OH)D (odds ratio [OR], 0.942; 95% confidence interval [CI], 0.893-0.994) and cholesterol (OR, 0.981; 95%CI, 0.969-0.992) levels, older age (OR, 1.043; 95%CI, 1.002-1.085), high ferritin (OR, 1.003; 95%CI, 1.001-1.005), and necroinflammation (OR, 2.235; 95%CI, 1.014-4.929) were independently associated with severe fibrosis (F3-F4) by multivariate logistic analysis. Seventy patients (41%) achieved SVR. By multivariate analysis, hepatic steatosis (OR, 0.971; 95%CI, 0.944-0.999), lower cholesterol (OR, 1.009; 95% CI, 1.000-1.018), and 25(OH)D levels (OR, 1.039; 95%CI, 1.002-1.077) were independently associated with no SVR. CONCLUSION: G1 CHC patients had low 25(OH)D serum levels, possibly because of reduced CYP27A1 expression. Low vitamin D is linked to severe fibrosis and low SVR on interferon (IFN)-based therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
Holick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.362 · Cited by 1,665
Hypovitaminosis D is associated with insulin resistance and β cell dysfunction
Chiu, K. C., Chu, A., Go, V. L. W., & Saad, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.820 · Cited by 1,642
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,576
Colloredo, G., Guido, M., Sonzogni, A., & Leandro, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00191-0 · Cited by 869
Expression of 1,25-Dihydroxyvitamin D3 Receptor in the Immune System
Veldman, C. M., Cantorna, M. T., & DeLuca, H. F. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1605 · Cited by 710
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system
Cantorna, M. T., Zhu, Y., Froicu, M., & Wittke, A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1717s · Cited by 704
Enzymes involved in the activation and inactivation of vitamin D
PROSSER, D., & JONES, G. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.10.005 · Cited by 658
Cited by
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., Plauth, M., & Parés, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.024 · Cited by 1,130
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622
Vitamin D and the anti-viral state
Beard, J. A., Bearden, A., & Striker, R. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.12.006 · Cited by 423
Vitamin D and Chronic Diseases
Wang, H., Chen, W., Li, D., Yin, X., Zhang, X., Olsen, N., & Zheng, S. G. (2017) · Aging and disease · doi:10.14336/ad.2016.1021 · Cited by 419
Schwalfenberg, G. K. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000174 · Cited by 414
Barchetta, I., Angelico, F., Ben, M. D., Baroni, M. G., Pozzilli, P., Morini, S., & Cavallo, M. G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-85 · Cited by 323
The Non-Genomic Actions of Vitamin D
Hii, C., & Ferrante, A. (2016) · Nutrients · doi:10.3390/nu8030135 · Cited by 322
Abramovitch, S., Dahan-Bachar, L., Sharvit, E., Weisman, Y., Tov, A. B., Brazowski, E., & Reif, S. (2011) · Gut · doi:10.1136/gut.2010.234666 · Cited by 286
The interplay between vitamin D and viral infections
Teymoori‐Rad, M., Shokri, F., Salimi, V., & Marashi, S. M. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2032 · Cited by 279
The role of vitamin D and vitamin D binding protein in chronic liver diseases
Pop, T. L., Sîrbe, C., Benţa, G., Mititelu, A., & Grama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810705 · Cited by 105
Vitamin D and liver fibrosis: molecular mechanisms and clinical studies
Udomsinprasert, W., & Jittikoon, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.140 · Cited by 99
Abramovitch, S., Sharvit, E., Weisman, Y., Bentov, A., Brazowski, E., Cohen, G., Volovelsky, O., & Reif, S. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2013 · Cited by 82
Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease
Agmon-Levin, N., Kopilov, R., Selmi, C., Nussinovitch, U., Sánchez-Castañón, M., López-Hoyos, M., Amital, H., Kivity, S., Gershwin, E. M., & Shoenfeld, Y. (2015) · Immunologic Research · doi:10.1007/s12026-014-8594-0 · Cited by 57
Vitamin D modulates biliary fibrosis in ABCB4-deficient mice
Hochrath, K., Stokes, C. S., Geisel, J., Pollheimer, M. J., Fickert, P., Dooley, S., & Lammert, F. (2014) · Hepatology International · doi:10.1007/s12072-014-9548-2 · Cited by 36
Metadata
- Authors
- Petta, S., Cammà, C., Scazzone, C., Tripodo, C., Di Marco, V., Bono, A., Cabibi, D., Licata, G., Porcasi, R., Marchesini, G., & Craxí, A.
- Venue
- Hepatology
- Published
- 2010-04
- Volume
- 51
- Issue
- 4
- Pages
- 1158-1167
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2026216011
- Cited by
- 448
- References
- 34
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.